CAS 130308-48-4
:Icatibant
Description:
Icatibant is a synthetic peptide and a selective bradykinin B2 receptor antagonist, primarily used in the treatment of hereditary angioedema, a condition characterized by recurrent episodes of severe swelling. Its mechanism of action involves blocking the effects of bradykinin, a peptide that promotes vasodilation and increases vascular permeability, thereby alleviating the symptoms associated with angioedema. Icatibant is administered via subcutaneous injection and is known for its rapid onset of action. The substance has a relatively short half-life, necessitating careful dosing to maintain therapeutic levels. In terms of chemical structure, Icatibant is a nonapeptide, which contributes to its specificity and efficacy in targeting the bradykinin receptor. Its safety profile is generally favorable, with common side effects including injection site reactions and gastrointestinal disturbances. Overall, Icatibant represents a significant advancement in the management of hereditary angioedema, providing patients with a targeted therapeutic option to control acute attacks.
Formula:C59H89N19O13S
InChI:InChI=1/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38?,39-,40-,41-,42-,43?,44?,45?,46?/m0/s1
Synonyms:- Firazyr
- Hoe140
- L-Arginine, D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-L-(2alpha,3abeta,7abeta)-octahydro-1H-indole-2-carbonyl-
- (2S)-2-({[(3aS,7aS)-1-({2-[(2S)-2-{[(2S)-2-({[({(4R)-1-[(1-{2-({(2R)-2-amino-5-[(diaminomethylidene)amino]pentanoyl}amino)-5-[(diaminomethylidene)amino]pentanoyl}pyrrolidin-2-yl)carbonyl]-4-hydroxypyrrolidin-2-yl}carbonyl)amino]acetyl}amino)-3-(thiophen-2-yl)propanoyl]amino}-3-hydroxypropanoyl]-1,2,3,4-tetrahydroisoquinolin-3-yl}carbonyl)octahydro-1H-indol-2-yl]carbonyl}amino)-5-[(diaminomethylidene)amino]pentanoic acid (non-preferred name)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
L-Arginine, D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-
CAS:Formula:C59H89N19O13SPurity:98%Color and Shape:SolidMolecular weight:1304.5225Icatibant
CAS:Icatibant is a selective and specific antagonist of the bradykinin B2 receptor (IC50 and Ki: 1.07 nM and 0.798 nM respectively).Formula:C59H89N19O13SPurity:98%Color and Shape:White SolidMolecular weight:1304.52Icatibatide Acetate
CAS:Formula:C59H89N19O13SPurity:95%~99%Color and Shape:White to Off-white PowderMolecular weight:1304.52Icatibant
CAS:<p>Icatibant is a 10 amino acid peptidomimetic of bradykinin and a selective antagonist to the bradykinin B2 receptor. Icabinant has been used for the treatment of attacks in patients with hereditary angioedema. Recent evidence has shown a link between dysregulated bradykininâmediated inflammation and acute respiratory distress syndrome (ARDS), a common complication in COVID-19 patients. Icatibant was proposed to inhibit excessive activation of the bradykinin B2 receptor during the SARS-CoV-2 infection, reducing the risk of ARDS._x000D_</p>Formula:C59H89N19O13SPurity:Min. 95%Color and Shape:PowderMolecular weight:1,304.52 g/molIcatibant Peptide Fragment [1-7] TFA Salt
CAS:Controlled ProductFormula:C34H55N13O10S•xC2HF3O2Color and Shape:NeatMolecular weight:837.95 + (114.02)xD-Arginyl-[Hyp3,Thi5,D-Tic7,Oic8]-Bradykinin
CAS:<p>D-Arginyl-[Hyp3,Thi5,D-Tic7,Oic8]-Bradykinin is a synthetic peptide that is used as a research tool. It has been shown to activate ion channels and receptor proteins in studies on cell biology and pharmacology. This peptide also inhibits the binding of ligands to their receptors, which may be due to its structural similarity with other peptides that bind to the same receptor. D-Arginyl-[Hyp3,Thi5,D-Tic7,Oic8]-Bradykinin is an inhibitor of protein interactions.</p>Formula:C59H89N19O13SPurity:Min. 95%Molecular weight:1,304.5 g/mol






